Consistently, microscopic images of the immunofluorescence staining demonstrated that the population of CD4+, CD8+ tumor-infiltrating lymphocytes and IFN-β expression were markedly enhanced via US-initiated SPDT synergized with STING agonists (Fig. 6j). The gene discussed is STING1; the disease is neoplasm.